BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 322390)

  • 1. Immunotherapy of cancer.
    Holmes EC; Morton DL; Eilber FR
    West J Med; 1977 Feb; 126(2):102-9. PubMed ID: 322390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of human cancer.
    Hersh EM; Gutterman JU; Mavligit GM
    Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant immunotherapy.
    Goodnight JE; Morton DL
    Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trials of immunotherapy in lung cancer].
    Budzyński W; Orłowski TM
    Wiad Lek; 1984 Jul; 37(13):997-1003. PubMed ID: 6393588
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of cancer in man.
    Carter SK
    Am Sci; 1976; 64(4):418-23. PubMed ID: 786091
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of intramural injection of immunotherapeutic agents on bladder histology and systemic humoral response.
    Albert NE; Sparks FC; Lytton B
    Invest Urol; 1978 Sep; 16(2):134-9. PubMed ID: 361626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of clinical immunotherapy.
    Woodruff MF
    Transplant Proc; 1979 Mar; 11(1):1077-81. PubMed ID: 377611
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G; Shaklee CL; Mak TW; Ulich TR
    Cell Immunol; 1999 May; 193(2):155-61. PubMed ID: 10222057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of solid tumor.
    Holmes EC
    Surg Clin North Am; 1979 Apr; 59(2):371-80. PubMed ID: 375448
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 16. The methanol extract residue (MER) of bacillus calmette-guerin in cancer immunotherapy.
    Domenick NP
    Nurs Clin North Am; 1978 Jun; 13(2):369-80. PubMed ID: 353752
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin.
    Ruitenberg EJ; Steerenberg PA
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy.
    Mathé G; Florentin I; Olsson L; Bruley-Rosset M; Schulz J; Kiger N; Orbach-Arbouys S; Schwarzenberg L; Pouillart P; de Vassal F
    Cancer Treat Rep; 1978 Nov; 62(11):1613-21. PubMed ID: 103616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy].
    Bianucci P; Pastorino G
    Arch Sci Med (Torino); 1980; 137(1):33-40. PubMed ID: 7458652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.